Is a complete NPCE research report available?

No complete published report is available for NeuroPace, Inc. (NPCE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

NeuroPace, Inc. (NPCE)

NASDAQ: NPCE · USD

$13.8

+0.11 (+0.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NPCE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	468.8M
Revenue (ttm)	99.5M
Net income (ttm)	-21.6M
EPS (ttm)	-$0.65
Shares out	34.1M
Volume	229,132
Beta	1.89
Price target	$20.2	+47.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 99.5M
Net income (ttm): -21.6M
EPS (ttm): -$0.65
Market cap: 468.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NPCE indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001528287
Company name	NeuroPace, Inc.
Country	United States
Country code	US
Cusip	641288105
Employees	220
Employees Change	11%
Employees Change Percent	5.26
Enterprise value	$485.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	19.92
IPO Date	2021-04-22
Isin	US6412881053
Last refreshed	2026-07-31
Market cap	$468.8M
Market cap category	Small-Cap
Price	$13.75
Price currency	USD
Rev Per Employee	452,409.09x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	3841
Symbol	NPCE
Website	https://www.neuropace.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.6%
EV Sales Forward	4.62x
EV/Sales	4.88x
FCF yield	-2.1%
P/B ratio	32x
P/S ratio	4.71x
PS Forward	4.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-16.84%
EBITDA Margin	-14.83%
Gross margin	78.29%
Gross Profit	$77.9M
Gross Profit Growth	23.53%
Gross Profit Growth Q	4.07%
Gross Profit Growth3 Y	31.07%
Gross Profit Growth5 Y	19.7%
Net Income	$-21.6M
Net Income Growth Years	3%
Pretax Margin	-21.67%
Profit Margin	-21.67%
Profit Per Employee	$-98,023
ROA	-10.02
Roa5y	-15.03
ROCE	-20.26
ROE	-111.4
Roe5y	-132.2
ROIC	-11.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	56.65%
Cagr3y	49.79%
Cagr5y	-8.71%
EPS Growth Quarters	3
EPS Growth Years	6
Revenue Growth	18.06x
Revenue Growth Q	-2.03x
Revenue Growth Years	6x
Revenue Growth3 Y	26.98x
Revenue Growth5 Y	18.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.95
Assets	$98.9M
Cash	$54M
Current Assets	$87M
Current Liabilities	$16.2M
Debt	$70.5M
Debt Equity	$4.87
Equity	$14.5M
Interest Coverage	-2.46
Liabilities	$84.4M
Long Term Assets	$11.9M
Long Term Liabilities	$68.3M
Net Cash	$-16.5M
Net Cash By Market Cap	$-3.52
Net Debt Equity	$1.14
Tangible Book Value	$14.5M
Tangible Book Value Per Share	$0.43
WACC	13.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.38
Inventory Turnover	1.43
Net Working Capital	$19M
Quick ratio	4.25
Working Capital	$70.8M
Working Capital Turnover	$1.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.22%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	56.61%
200-day SMA	15.08
3Y total return	236.19%
50-day SMA	15.99
50-day SMA vs 200-day SMA	50over200
5Y total return	-36.58%
All Time High	27.38
All Time High Change	-49.78%
All Time High Date	2021-04-27
All Time Low	1.22
All Time Low Change	1,027.05%
All Time Low Date	2022-12-28
ATR	0.85
Beta	1.89
Beta1y	0.99
Beta2y	0.87
Ch YTD	-10.95
High	14.11
High52	19.6
High52 Date	2026-05-08
High52ch	-29.85%
Low	13.51
Low52	7.56
Low52 Date	2025-08-13
Low52ch	81.81%
Ma50ch	-13.99%
Price vs 200-day SMA	-8.84%
RSI	34.08
RSI Monthly	52.19
RSI Weekly	43.45
Sharpe ratio	0.95x
Sortino ratio	1.84
Total Return	-11.22%
Tr YTD	-10.95
Tr1m	-16.82%
Tr1w	-6.34%
Tr3m	-16.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	1
Analyst Price Target Top	$22
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.2
Earnings Revenue Estimate	22,618,040x
Earnings Revenue Estimate Growth	-3.83x
Operating Income	$-16.8M
Operating margin	-16.84
Price target	$20.22
Price Target Change	$47.06
Price Target Change Top	$60

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,292,961%
Float Percent	68.32%
Net Borrowing	-2,072,000
Shares Insiders	3.93%
Shares Institutions	64.31%
Shares Out	34,093,745
Shares Qo Q	0.99%
Shares Yo Y	11.22%
Short Float	3.75%
Short Ratio	4.55
Short Shares	2.56

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-20.6M
Adjusted OCF	-20,165,000
Average Volume	178,340.8x
Bv Per Share	0.43
CAPEX	$-412,000
Ch1m	-16.82
Ch1w	-6.34
Ch1y	56.61
Ch3m	-16.87
Ch3y	236.2
Ch5y	-36.58
Ch6m	-10.25
Change	0.81%
Change From Open	0.44
Close	13.64
Days Gap	0.37
Depreciation Amortization	249,000
Dollar Volume	3,150,565
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-16.8M
EBITDA	$-14.8M
EPS	$-0.65
F Score	4
FCF	$-9.8M
FCF EV Yield	-2.03x
FCF Per Share	$-0.29
Financing CF	-1,674,000
Fiscal Year End	December
Founded	1,997
Investing CF	-412,000
Ipr	-19.12
Iprfo	-40.86
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	15.61
Ma150ch	-11.89%
Ma20	15.86
Ma20ch	-13.29%
Net CF	-11,510,000
Next Earnings Date	2026-08-11
Open	13.69
Optionable	Yes
Position In Range	40
Ppne	10,962,000
Price Date	2026-07-30
Ptbv Ratio	32.43
Relative Volume	1.28x
Revenue	99,530,000x
SBC By Revenue	10.79x
Share Based Comp	10,741,000
Tr6m	-10.25%
Us State	California
Volume	229,132
Z Score	-3.66

NeuroPace, Inc. (NPCE)

Coverage state: Market snapshot only — no published research

Generate the first NPCE analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NPCE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NPCE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NPCE

Frequently asked questions